Image

Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype

Study of Electrochemotherapy for Visceral Tumors

Recruiting
18-99 years
All
Phase N/A
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates electrochemotherapy for treating visceral tumors. The purpose of the study is to evaluate the safety and effectiveness of electrochemotherapy in improving response rates for visceral lesions.

  • Who can participate: Adults aged 18 and older with primary or secondary visceral tumors can participate.
  • Study details: Participants will receive electrochemotherapy, which involves using electrical pulses to enhance the delivery of a chemotherapy drug.
Print
Study details
    Primary Visceral Tumors of Any Histotype
    Visceral Lesions
    Liver Cancer
    Liver Metastasis Colon Cancer
    Melanoma
    Primary Pancreatic Tumor
    Retroperitoneal Sarcoma
    Abdominal and/or Peritoneal Localizations
    Merkel Cell Carcinoma
    Squamous Cell Carcinoma
    Secondary Visceral Localizations of Any Histotype
    Non-melanoma Skin Cancer

NCT06753136

Istituto Oncologico Veneto IRCCS

30 July 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.